SENSEX NIFTY

Dr Reddys Laboratories

Feb 28, 2017 at 09:13 | Source: Moneycontrol.com
Morgan Stanley sees limited impact on HPCL/BPCL if government transfers ownership to ONGC. ONGC's leverage could rise in the near-term and HPCL/BPCL could lower ONGC's leverage only by FY20-21, it feels.
Feb 28, 2017 at 07:55 | Source: Moneycontrol.com
Indian ADRs ended mixed on Monday. Tata Motors slipped 0.32 percent and HDFC Bank shed 0.03 percent.
Feb 27, 2017 at 18:32 | Source: Moneycontrol.com
The company said the ramping up of its specialty portfolio would initially focus on acquisitions, as developing a product would take around three years.
Feb 27, 2017 at 12:55 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Amtek Auto,Reliance, Dr Reddys Laboratories, Reliance Infrastructure, Reliance Defence, GMR Infrastructure, and ENIL.
Feb 27, 2017 at 09:35 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can sell State Bank of India, Pidilite Industries and Dr Reddy's Laboratories and buy Tata Consultancy Services and Divis Laboratories.
Feb 25, 2017 at 14:22 | Source: CNBC-TV18
Watch NSE FinWiz Season 4 visits Dr Reddy's Hyderabad campus to help the employees with their personal finance goals.
Feb 25, 2017 at 10:03 | Source: Moneycontrol.com
In the banking space, ICICI Bank was down 0.01 percent at USD 8.46 and HDFC Bank slipped 0.6 percent at USD 71.52.
Feb 24, 2017 at 21:20 | Source: Moneycontrol.com
Faced with increasing regulatory scrutiny -- Indian drug makers working more closely then ever before on Friday said they have been investing on automation, simplifying and standardizing systems and working on building culture of compliance within their organizations -- as they dont want to be seen as outliers in terms of regulatory compliance.
Feb 24, 2017 at 09:14 | Source: Moneycontrol.com
Indian ADRs ended mixed on Thursday. Tata Motors declined 0.41 percent and Wipro rose 1.46 percent.
Feb 23, 2017 at 21:27 | Source: Moneycontrol.com
Data reliability or data integrity are often linked to allegations of data falsification or manipulation, which are cited as main reasons by US FDA for pulling up Indian companies as part of its regulatory scrutiny.
Messages on Dr Reddys Laboratories »

Wire News

Platinum Member

716 Followers

News Now  

Drug firm Dr Reddy's Laboratories today said the US health regulator has made three observations after completing inspection of its Miryalaguda facility.

9.10 PM Feb 21st

Wire News

Platinum Member

716 Followers

News Now  

Drug major Dr Reddy's Laboratories today said there are no claims against the company for monetary damages after it received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.

1.46 PM Feb 17th

Market Statistician

Platinum Member

20461 Followers

Dr Reddys Labs  

Dr Reddys Laboratories has touched a 52-week low of Rs 2,803.50. At 11:14 hrs, the share was quoting at Rs 2,879.10, down Rs 30.95, or 1.06%. See more

11.15 AM Feb 16th

Wire News

Platinum Member

716 Followers

News Now  

Drug major Dr Reddy's Laboratories today said it has received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.

11.14 AM Feb 16th

BSE/NSE Announcer

Platinum Member

21462 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding a press release dated February 16, 2017, titled "Dr. Reddys announces US district courts opinion relating to patent infringement".

10.01 AM Feb 16th

BSE/NSE Announcer

Platinum Member

21462 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2016, with the United States Securities Exchange Commission on February 10, 2017. A copy

1.43 PM Feb 13th

Manisham

New Member

0 Follower

Divis Labs  

maam what are you views on Dr Reddys laboratories?

12.18 PM Feb 3rd

Wire News

Platinum Member

716 Followers

News Now  

South Korean firm Mezzion Pharma has filed a suit against Dr Reddy's Laboratories in the US alleging that the Indian company hid "significant deficiencies" and misrepresented compliance with the Food and Drug Administration (FDA) cGMP practices.

5.34 PM Jan 27th

BSE/NSE Announcer

Platinum Member

21462 Followers

Dr Reddys Labs  

The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in The Financial Express on January 26, 2017 titled "Korean biotech firm Mezzion Pharma files suit against Dr Reddys Laboratories."The reply is awaited.

12.37 PM Jan 27th

BSE/NSE Announcer

Platinum Member

21462 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding a press release dated January 23, 2017, titled "Dr. Reddys Q3-FY17 Earnings Call Notification".Dr. Reddys to release Q3 FY17 results on Feb 4, 2017 Earnings call slated for Feb 4, 6.30 PM IST / 8.00 AM EST

11.29 AM Jan 23rd

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.